Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
CheckMate 012: Safety and Efficacy of First-Line...
Conference

CheckMate 012: Safety and Efficacy of First-Line Nivolumab and Ipilimumab in Advanced NSCLC

Authors

Antonia SJ; Gettinger SN; Goldman J; Brahmer J; Borghaei H; Chow LQ; Ready NE; Gerber DE; Juergens R; Shepherd F

Volume

11

Pagination

pp. S250-S251

Publisher

ELSEVIER SCIENCE INC

Publication Date

November 1, 2016

DOI

10.1016/j.jtho.2016.09.008

Conference proceedings

JOURNAL OF THORACIC ONCOLOGY

Issue

11

ISSN

1556-0864